In addition, variation in the expression of the mitochondrial transcription factor TFAM, a downstream effector of PGC1α, and of the complex IV subunit COX1, a target gene of TFAM, tended to be reduced in COPD myotubes compared to healthy muscle cells upon EPS (Figure 5). This evidence concerns the gene TFAM and chronic obstructive pulmonary disease.